QA: AV Therapeutics Inc in us_food/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001537293_2014_AV_Therapeutics_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning No stock price available subcommand.plot {}
warning Missing logo subcommand.report {}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001537293', 'Assets': 9204, 'AssetsCurrent': 4204, 'Expenses': 0, 'GeneralAndAdministrativeExpense': 0, 'IntangibleAssets': 0, 'Liabilities': 8673, 'LiabilitiesAndStockholdersEquity': 9204, 'LiabilitiesCurrent': 8673, 'LiabilitiesLongTerm': 0, 'NetIncome': -43865, 'PropertyPlantAndEquipment': 5000, 'Revenues': 0, 'SellingAndMarketingExpense': 0, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 531, 'remainder_NetIncome': -43865, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('EntityCommonStockSharesOutstanding')"}

Graph

Absolute values for 0001537293, AV Therapeutics Inc

  xvar xval
0 IntangibleAssets 147,597
1 AssetsCurrent 636,251
2 PropertyPlantAndEquipment 1,079
3 remainder_Assets 0
4 LiabilitiesLongTerm 0
5 LiabilitiesCurrent 750,755
6 remainder_Liabilities 0
7 GeneralAndAdministrativeExpense 0
8 SellingAndMarketingExpense 0
9 remainder_Expenses 905,396
10 remainder_Revenues 0
11 remainder_NetIncome -524
12 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 784,927
1 Liabilities 750,755
2 Expenses 905,396
3 Revenues 0
4 StockholdersEquity 34,172
5 NetIncome -905,920
6 ComprehensiveNetIncome -905,920
7 BaseVar 1,220,801
8 EconomicCapitalRatiobeforeLimitedLiability -1.16
9 EconomicCapitalRatio 1.13

Edgar->Model Mapping

Feature Distribution